Desensitization to hydroxychloroquine: Alternative interpretations

Journal of Rheumatology

Volumn 34, Issue 2, 2007, Pages 253-255

  Sontheimer, Richard D ^a,b  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPENICILLIN; AMINOQUINOLINE DERIVATIVE; AMOXICILLIN; AMPICILLIN; ANTIMALARIAL AGENT; EOTAXIN; GRANZYME B; HYDROXYCHLOROQUINE; INTERLEUKIN 5; PERFORIN; RANTES;

ANGIONEUROTIC EDEMA; BONE MARROW TOXICITY; BULLOUS DERMATITIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL FEATURE; DELAYED HYPERSENSITIVITY; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; EDITORIAL; EOSINOPHILIA; ERYTHEMA; ERYTHEMA ANNULARE CENTRIFUGUM; ERYTHEMA MULTIFORME; ERYTHEMA NODOSUM; ERYTHRODERMA; EXFOLIATIVE DERMATITIS; FIXED DRUG ERUPTION; HUMAN; INFECTIOUS MONONUCLEOSIS; LICHENOID ERUPTION; MALARIA; PHOTODERMATOSIS; PHOTOSENSITIVITY; PRIORITY JOURNAL; PROGNOSIS; PUSTULOSIS; RASH; SKIN ALLERGY; STEVENS JOHNSON SYNDROME; URTICARIA;

ANTIRHEUMATIC AGENTS; DESENSITIZATION, IMMUNOLOGIC; DRUG ERUPTIONS; DRUG HYPERSENSITIVITY; DRUG TOLERANCE; HUMANS; HYDROXYCHLOROQUINE; RHEUMATIC DISEASES;

EID: 33846977675     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (10)

1. Mates M, Zevin S, Breuer GS, Navon P, Nesher G. Desensitization to hydroxychloroquine - experience of 4 patients. J Rheumatol 2006;33:814-6.
2. Lerch M, Pichler WJ. The immunological and clinical spectrum of delayed drug-induced exanthems. Curr Opin Allergy Clin Immunol 2004;4:411-9.
3. Litt JZ. Litt's pocketbook of drug eruptions and interactions. 3rd ed. Boca Raton: Parthenon Publishing; 2004.
4. Wallace DJ. The use of quinacrine (Atabrine) in rheumatic diseases: A re-examination. Semin Arthritis Rheum 1989;18:282-97.
5. Lammintausta K, Kortekangas-Savolainen O. Oral challenge in patients with suspected cutaneous adverse drug reactions: findings in 784 patients during a 25-year-period. Acta Derm Venereol 2005;85:491-6.
6. Bigby M. Rates of cutaneous reactions to drugs. Arch Dermatol 2001;137:765-70.
7. Pelle MT, Callen JP. Adverse cutaneous reactions to hydroxychloroquine are more common in patients with dermatomyositis than in patients with cutaneous lupus erythematosus. Arch Dermatol 2002;138:1231-3.
8. Reveuz J, Valeyrie-Allanore L. Drug reactions. In: Bolognia JL, Jorrizo JL, Rapini RP, editors. Dermatology. 1st ed. London: Mosby; 2003:333-53.
9. Yawalkar N. Drug-induced exanthems. Toxicology 2005;209:131-4.
10. Verbeeck RK, Junginger HE, Midha KK, Shah VP, Barends DM. Biowaiver monographs for immediate release solid oral dosage forms based on biopharmaceutics classification system (BCS) literature data: chloroquine phosphate, chloroquine sulfate, and chloroquine hydrochloride. J Pharm Sci 2005;94:1389-95.